News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,852 Results
Type
Article (3238)
Company Profile (6)
Press Release (72608)
Section
Business (18813)
Career Advice (23)
Deals (3412)
Drug Delivery (2)
Drug Development (9042)
Employer Resources (3)
FDA (3215)
Job Trends (1454)
News (34120)
Policy (2742)
Tag
Academia (307)
Accelerated approval (3)
Adcomms (2)
Allergies (2)
Alliances (4085)
ALS (2)
Alzheimer's disease (27)
Antibody-drug conjugate (ADC) (39)
Approvals (3283)
Artificial intelligence (30)
Autoimmune disease (5)
Bankruptcy (27)
Best Places to Work (1322)
Biosimilars (19)
Biotechnology (3)
Bladder cancer (56)
Brain cancer (20)
Breast cancer (120)
Cancer (1085)
Cardiovascular disease (25)
Career advice (23)
CAR-T (13)
Cell therapy (51)
Cervical cancer (8)
Clinical research (7946)
Collaboration (119)
Compensation (34)
Complete response letters (3)
COVID-19 (131)
CRISPR (1)
C-suite (54)
Cystic fibrosis (2)
Data (884)
Depression (2)
Diabetes (34)
Diagnostics (439)
Digital health (6)
Drug discovery (8)
Duchenne muscular dystrophy (3)
Earnings (9478)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (10961)
Executive appointments (74)
FDA (3698)
Frontotemporal dementia (1)
Funding (121)
Gene editing (1)
Gene therapy (43)
GLP-1 (52)
Government (297)
Guidances (58)
Healthcare (3108)
Huntington's disease (2)
Immunology and inflammation (16)
Immuno-oncology (15)
Indications (17)
Infectious disease (133)
Inflammatory bowel disease (13)
Influenza (1)
Intellectual property (22)
Interviews (2)
IPO (1522)
Job creations (171)
Job search strategy (22)
JPM (5)
Kidney cancer (5)
Labor market (1)
Layoffs (35)
Legal (454)
Liver cancer (35)
Longevity (1)
Lung cancer (178)
Lymphoma (39)
Machine learning (3)
Management (2)
Manufacturing (21)
MASH (2)
Medical device (4388)
Medtech (4409)
Mergers & acquisitions (1971)
Metabolic disorders (50)
Multiple sclerosis (1)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (77)
Neurotech (1)
NextGen: Class of 2026 (790)
Non-profit (291)
Now hiring (1)
Obesity (12)
Opinion (5)
Ovarian cancer (35)
Pain (54)
Pancreatic cancer (71)
Parkinson's disease (21)
Patents (51)
Patient recruitment (75)
People (4861)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (3006)
Phase 2 (3606)
Phase 3 (2497)
Pipeline (592)
Policy (1)
Postmarket research (183)
Preclinical (1038)
Prostate cancer (40)
Radiopharmaceuticals (21)
Rare diseases (29)
Real estate (350)
Regulatory (2489)
Reports (4)
Research institute (259)
Schizophrenia (6)
Series A (13)
Series B (18)
Service/supplier (1)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (4)
Startups (290)
Stomach cancer (4)
Supply chain (5)
Vaccines (54)
Venture capital (5)
Weight loss (6)
Women's health (15)
Date
Last 7 days (55)
Last 30 days (192)
Last 365 days (3146)
2026 (251)
2025 (3231)
2024 (3966)
2023 (4956)
2022 (8420)
2021 (7776)
2020 (6496)
2019 (5252)
2018 (3971)
2017 (4038)
2016 (3526)
2015 (3933)
2014 (2710)
2013 (2259)
2012 (2360)
2011 (2297)
2010 (1997)
Location
Africa (25)
Alabama (4)
Alaska (2)
Arizona (32)
Asia (4391)
Australia (552)
California (1041)
Canada (258)
China (129)
Colorado (58)
Connecticut (29)
Delaware (35)
Europe (8481)
Florida (273)
Georgia (105)
Idaho (10)
Illinois (145)
India (6)
Indiana (51)
Iowa (1)
Japan (38)
Kansas (8)
Kentucky (1)
Louisiana (2)
Maryland (117)
Massachusetts (663)
Michigan (51)
Minnesota (101)
Mississippi (2)
Missouri (43)
Montana (12)
Nebraska (6)
Nevada (9)
New Hampshire (14)
New Jersey (397)
New Mexico (2)
New York (274)
North Carolina (160)
Northern California (457)
Ohio (48)
Oklahoma (2)
Oregon (9)
Pennsylvania (268)
Rhode Island (12)
South America (43)
South Carolina (5)
Southern California (448)
Tennessee (55)
Texas (249)
United States (4288)
Utah (26)
Virginia (22)
Washington State (49)
West Virginia (1)
Wisconsin (11)
75,852 Results for "checkpoint surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Checkpoint Surgical Marks Milestone with the First Use of Investigational Nerve Regeneration System Regen10® in the FASTR-TEN Clinical Trial
September 5, 2025
·
1 min read
Cardiovascular disease
Deep Dive: Checkpoint Inhibitors at a Crossroads
A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures to high-potential targets like VEGF,
BioSpace
explores what’s on the horizon in immuno-oncology.
May 19, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
February 2, 2026
·
7 min read
Press Releases
ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer
January 14, 2026
·
9 min read
Press Releases
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
December 4, 2025
·
8 min read
Press Releases
Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint Antibody in Solid Tumors
December 16, 2025
·
4 min read
Press Releases
HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer
November 10, 2025
·
6 min read
Press Releases
Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer
November 18, 2025
·
3 min read
Press Releases
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
September 26, 2025
·
4 min read
Press Releases
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors
November 11, 2025
·
10 min read
1 of 7,586
Next
